NCT06031233 2026-03-30
MINUTE
Isala
Phase 4 Recruiting
Clinical Trials
5 trialsNCT07059494 2026-03-23
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Icahn School of Medicine at Mount Sinai
Phase 4 Recruiting
NCT05525767 2025-12-11
Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer
Hebei Medical University Fourth Hospital
Phase 4 Recruiting
NCT06550453 2024-11-12
Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer
Xijing Hospital
Phase 4 Recruiting
NCT05185505 2023-02-01
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
The Methodist Hospital Research Institute
Phase 4 Recruiting